Kao Corporation

Shunichi Akiba

Katsutoshi Ara

Hiroshi Kusuoku

Ichiro Mori

Yoshinori Nishizawa

Shigeyoshi Tanaka

Hirohiko Ishida

Toyoki Hagura

Sakuya Tanaka

Akira Fuji

Provided are a novel &#x3b2;-glucuronidase inhibitor including a compound selected from a macrocyclic ketone, a ketone, a macrocyclic lactone, a macrocyclic oxalactone, an ester, an aldehyde, an alcohol, and a terpene of specific kinds, and an environmental hygiene product and a sanitary product each containing the &#x3b2;-glucuronidase inhibitor. Also provided are a composition for suppressing the generation of urine odor and a method of suppressing the generation of urine odor each using a &#x3b2;-glucuronidase inhibitor.

&#x3b2;-glucuronidase inhibitor

Provided is a deodorant composition containing (A) an extract of a plant selected from phellodendron (or), ginkgo (),, licorice () and gardenia (), and (B) an unsaturated fatty acid. This deodorant composition has benefits such as an excellent deodorant effect and even if it contains powder, it does not leave substantially any white residue on the skin.

Deodorant composition

The invention contemplates drugs useful for maintenance or promotion at sites of regenerating nerves and for prevention or treatment of pathological conditions caused by denaturation or cell damage in the nervous system. Thus, the invention provides an apolipoprotein D degradation inhibitor containing lauric acid or oleic acid as an active ingredient.

Apolipoprotein D degradation inhibitor

Citral acetal

Growing community of inventors

Tochigi, Japan

Shunichi Akiba